+(91) 79 4891 1722

info@ralingtonpharma.com

Docetaxel

Docetaxel is a clinicallywell-established anti-mitotic chemotherapy medication that works by interferingwith cell division. Docetaxel is an anti-cancer chemotherapy drug.

Ralington pharma LLP (India), a globalmanufacturer and supplier for Docetaxel, 114977-28-5 (125354-16-7) for R&D,Pilot or Commercials  Quantities withPharmacopeial Grade USP/ EP/ BP/ IP/ JP/In-House.

Docetaxel, 114977-28-5(125354-16-7) available with USDMF,EDMF,DMF, USFDA, EUGMP, GMP, ISO CERTIFIED,WHO-GMP and DMF as per therequirement. Product supply in Standard Packaging & labeling as per FDAalong with supportive documentation. We can also offer Intermediates of  Docetaxel, 114977-28-5 (125354-16-7).

ProductType : API
Molecular Formula : C43H53NO14
CASNo : 114977-28-5 (125354-16-7)
Grades : CTD,USDMF,EDMF,GMP,USP,BP,EP,DMF,IP
Molecular Weight : 807.88
Synonym : N-Debenzoyl-N-(tert-butoxycarbonyl)taxol,N-debenzoyl-N-tert-butoxycarbonyl-10-deacetyl taxol; Taxotere,,

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

Top